Tyropanoic acid: Difference between revisions
No edit summary |
m (Protected "Tyropanoic acid": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite))) |
||
(One intermediate revision by one other user not shown) | |||
Line 5: | Line 5: | ||
|ImageSize=200px | |ImageSize=200px | ||
| ImageFile1 = Tyropanoic_acid_3D_ball.png | | ImageFile1 = Tyropanoic_acid_3D_ball.png | ||
| ImageSize1 = | | ImageSize1 = 250px | ||
| ImageAlt1 = Ball-and-stick model of the tyropanoic acid molecule | | ImageAlt1 = Ball-and-stick model of the tyropanoic acid molecule | ||
|IUPACName=2-[(3-butanamido-2,4,6-triiodophenyl)methyl]butanoic acid | |IUPACName=2-[(3-butanamido-2,4,6-triiodophenyl)methyl]butanoic acid |
Latest revision as of 17:22, 20 August 2015
Names | |
---|---|
IUPAC name
2-[(3-butanamido-2,4,6-triiodophenyl)methyl]butanoic acid
| |
Other names
2-[[2,4,6-triiodo-3-(1-oxobutylamino)phenyl]methyl]butanoic acid
| |
Identifiers | |
3D model (JSmol)
|
|
ChEMBL | |
ECHA InfoCard | Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). |
PubChem CID
|
|
| |
Properties | |
C15H18I3NO3 | |
Molar mass | 641.02 g/mol |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
WikiDoc Resources for Tyropanoic acid |
Articles |
---|
Most recent articles on Tyropanoic acid Most cited articles on Tyropanoic acid |
Media |
Powerpoint slides on Tyropanoic acid |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tyropanoic acid at Clinical Trials.gov Trial results on Tyropanoic acid Clinical Trials on Tyropanoic acid at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tyropanoic acid NICE Guidance on Tyropanoic acid
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tyropanoic acid Discussion groups on Tyropanoic acid Patient Handouts on Tyropanoic acid Directions to Hospitals Treating Tyropanoic acid Risk calculators and risk factors for Tyropanoic acid
|
Healthcare Provider Resources |
Causes & Risk Factors for Tyropanoic acid |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Tyropanoic acid and its salt sodium tyropanoate are radiocontrast agents used in cholecystography (X-ray diagnosis of gallstones). Trade names include Bilopaque, Lumopaque, Tyropaque, and Bilopac.[1] The molecule contains three heavy iodine atoms which obstruct X-rays in the same way as the calcium in bones to produce a visible image. After injection it is rapidly excreted into the bile.[2]
References
- ↑ "PubChem CID 5611".
- ↑ "Inhibition of hepatic binding of thyroxine by cholecystographic agents". J. Clin. Invest. 65 (5): 1032–40. May 1980. doi:10.1172/JCI109755. PMC 371433. PMID 7364937.
- Pages with script errors
- Articles without InChI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without UNII source
- Chemical articles with unknown parameter in Chembox
- Articles with changed EBI identifier
- ECHA InfoCard ID from Wikidata
- Articles containing unverified chemical infoboxes
- Chembox image size set
- Organoiodides
- Carboxylic acids
- Drug